3/14
10:36 am
lyra
Lyra Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
Lyra Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
3/14
08:04 am
lyra
Lyra Therapeutics, Inc. (NASDAQ: LYRA) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $2.00 price target on the stock.
Medium
Report
Lyra Therapeutics, Inc. (NASDAQ: LYRA) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $2.00 price target on the stock.
3/13
05:45 pm
lyra
Lyra Therapeutics GAAP EPS of -$1.43 misses by $0.10, revenue of $1.53M [Seeking Alpha]
Low
Report
Lyra Therapeutics GAAP EPS of -$1.43 misses by $0.10, revenue of $1.53M [Seeking Alpha]
3/13
04:01 pm
lyra
Lyra Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Low
Report
Lyra Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update